Perspective Therapeutics, Inc. (CATX)

2.43 +0.10 (+4.29%) USD  |  NYAM  |  Jan 20, 16:00
2.45 +0.02 (+0.82%) After-Hours: 07:30
More

Perspective Therapeutics SG&A Expense (% of Annual Revenues)

SG&A Expense (% of Annual Revenues) Chart

View SG&A Expense (% of Annual Revenues) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (% of Annual Revenues) Range, Past 5 Years

View SG&A Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (% of Annual Revenues) Benchmarks

View SG&A Expense (% of Annual Revenues) Benchmarks
Start Trial
Outset Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade
Catheter Precision, Inc. Upgrade